Jose M. Velarde - Publications

Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution.

Journal: Translational lung cancer research

Published: March 25, 2020

Prognostic value of stem cell markers in glioblastoma.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Published: September 10, 2019

Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.

Journal: Oncotarget

Published: May 10, 2019

Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients.

Journal: Scientific reports

Published: April 05, 2019

Real-world data on T-DM1 efficacy - results of a single-center retrospective study of HER2-positive breast cancer patients.

Journal: Scientific reports

Published: February 28, 2019

Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 13, 2019

A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer.

Journal: Oncology research and treatment

Published: August 22, 2018

Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer.

Journal: Oncotarget

Published: March 19, 2018

Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 05, 2018

Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.

Journal: Journal of neuro-oncology

Published: October 13, 2017